Alkermes plc.
ALKS
48 insider filings · Latest: Jun 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | Dec 9 10:24 PM | Hopkinson Craig C. | Proposed Sale | 61,151 | $32.07 | $2.0M | — | View → |
| Dec 5, 2024 | Dec 5 9:12 PM | Hopkinson Craig C. | Proposed Sale | 9,221 | $31.50 | $290.5K | — | View → |
| Dec 4, 2024 | Dec 4 9:19 PM | Hopkinson Craig C. | Proposed Sale | 14,349 | $30.77 | $441.6K | — | View → |
| Nov 27, 2024 | Nov 27 9:33 PM | Nichols Christian Todd | Proposed Sale | 5,208 | $29.15 | $151.8K | — | View → |
| Nov 11, 2024 | Nov 12 9:15 PM | Hopkinson Craig C. | Proposed Sale | 58,996 | $30.08 | $1.8M | — | View → |
| Nov 6, 2024 | Nov 6 9:33 PM | Hopkinson Craig C. | Proposed Sale | 10,471 | $29.53 | $309.2K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 2 1:05 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 11,356(D) | View → |
| Apr 11, 2026 | Apr 13 9:09 PM | Nancy LurkerDirector | Option Exercise | 3,751 | — | 3,752(D) | View → |
| Apr 1, 2026 | Apr 1 10:58 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 16,356(D) | View → |
| Mar 2, 2026 | Mar 5 1:21 AM | Joshua ReedSVP, Chief Financial Officer | Grant/Award | 97,284 | $30.25 | 30,854(D) | View → |
| Mar 2, 2026 | Mar 5 1:20 AM | POPS RICHARD FDirector, Director and CEO, Alkermes plc | Grant/Award | 88,843 | — | 88,843(D) | View → |
| Mar 2, 2026 | Mar 5 1:19 AM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Grant/Award | 29,209 | $30.25 | 14,176(D) | View → |
| Mar 2, 2026 | Mar 5 1:18 AM | Christian Todd NicholsSVP, Chief Commercial Officer | Grant/Award | 97,284 | $30.25 | 30,854(D) | View → |
| Mar 2, 2026 | Mar 5 1:17 AM | Blair Curtis JacksonEVP, Chief Operating Officer | Grant/Award | 138,978 | $30.25 | 44,078(D) | View → |
| Mar 2, 2026 | Mar 5 1:16 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 21,356(D) | View → |
| Mar 2, 2026 | Mar 5 1:16 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Grant/Award | 121,605 | $30.25 | 38,568(D) | View → |
| Mar 2, 2026 | Mar 5 1:15 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Grant/Award | 114,656 | $30.25 | 36,364(D) | View → |
| Feb 26, 2026 | Feb 27 9:40 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,747 | — | 5,493(D) | View → |
| Feb 26, 2026 | Feb 27 9:40 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 5,410 | — | 10,819(D) | View → |
| Feb 26, 2026 | Feb 27 9:39 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,322 | — | 16,645(D) | View → |
| Feb 26, 2026 | Feb 27 9:38 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 6,866 | — | 13,732(D) | View → |
| Feb 26, 2026 | Feb 27 9:37 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 6,866 | — | 13,732(D) | View → |
| Feb 23, 2026 | Feb 25 10:49 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,283 | — | 2,284(D) | View → |
| Feb 23, 2026 | Feb 25 10:48 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,407 | — | 6,408(D) | View → |
| Feb 23, 2026 | Feb 25 10:47 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,738 | — | 8,738(D) | View → |
| Feb 23, 2026 | Feb 25 10:46 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,689 | — | 7,690(D) | View → |